Issue 22, 2020

Organic/inorganic nanohybrids rejuvenate photodynamic cancer therapy

Abstract

The development of nanotechnology has changed the 100-year-old paradigm of photodynamic therapy (PDT), in which organic/inorganic hybrid nanomaterials have made great contributions. In this review, we first describe the mechanisms of PDT and discuss the limitations of conventional PDT. On this basis, we summarize recent progress in organic/inorganic nanohybrids-based photodynamic agents, highlighting how these nanohybrids can be programmed to overcome challenges in photodynamic cancer therapy.

Graphical abstract: Organic/inorganic nanohybrids rejuvenate photodynamic cancer therapy

Article information

Article type
Review Article
Submitted
12 janv. 2020
Accepted
25 févr. 2020
First published
26 févr. 2020

J. Mater. Chem. B, 2020,8, 4748-4763

Organic/inorganic nanohybrids rejuvenate photodynamic cancer therapy

C. Liang, X. Zhang, Z. Wang, W. Wang, M. Yang and X. Dong, J. Mater. Chem. B, 2020, 8, 4748 DOI: 10.1039/D0TB00098A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements